Search results for Medicine Stocks

Medicine Stocks Based on Genetic Algorithms: Returns up to 19.52% in 3 Days

Package Name: Medicine Stocks Recommended Positions: Long Forecast Length: 3 Days (5/8/26 - 5/12/26) I Know First Average: 3.92% Read The Full Forecast...

Goldman Sachs' 2 Favorite Under-the-Radar Stocks

Goldman Sachs calls Minimed Group a compelling play on the diabetes market and a potentially profitable stock, with a target price of $24. MiniMed produces insulin pump platforms a...

Best Healthcare Stocks to Buy in 2026

Novo Nordisk and Biogen are underpriced and stand to gain from new indications for their blockbuster therapies.

12 Health Care Stocks Moving In Friday's After-Market Session

Importance Rank:  1 read more

Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings

3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist

These companies boast significant upside potential.

Is This Healthcare Stock a Millionaire Maker?

If it can establish itself as a leading biotech in the future, it might be.

This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million

This clinical-stage biotech develops oral therapeutics for chronic diseases, with a pipeline centered on metabolic and pulmonary targets.

3 Healthcare Stocks Paying the Highest Dividends in the Sector Right Now

The highest-yielding healthcare stocks come with some side effects.

Praxis Precision Medicines (PRAX): One of the Best Upside Stocks

Got $1,000? Which of These Beaten-Down Healthcare Stocks Is Worth Buying?

These longtime market beaters may not have peaked yet.

GLP-1 trade? McKesson is your stock, this investor says

Goodreid Investment Counsel president and CEO Gordon Reid told BNN Bloomberg’s Market Call on April 23 that McKesson (McKesson Stock Quote, Chart, News, Analysts, Financials NYSE:M...

This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million

Structure Therapeutics advances oral therapies for chronic diseases, with a pipeline focused on metabolic and pulmonary conditions.

This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million

Structure Therapeutics advances oral therapies for chronic diseases, with a pipeline focused on metabolic and pulmonary conditions.

Pharma Stock in Focus After Receiving USFDA Approval for Benzonatate Capsules

Synopsis: The shares of this company rose 8.9 percent following a press release announcing USFDA approval for its Benzonatate Capsules, boosting investor confidence. The share of t...

EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline

Medicus Pharma to present Phase 1 Teverelix data showing dose-dependent estradiol suppression and long-acting profile at AACE 2026. Importance Rank: ...

3 Healthcare Stocks With the Most Durable Competitive Moats

These companies offer a clear path to sustained earnings growth.

2 Healthcare Stocks to Buy and 1 to Approach With Caution

Recent performances don't tell the whole story.

Want to Build Real Wealth in Healthcare? These Stocks Are Worth Considering

These companies are leaders in their fields.

Healthcare Stocks Are on Fire -- Don't Miss These Opportunities

The healthcare sector outperformed the rest of the market over the past week.

Healthcare Stock Surges 11% on Strong ANDA Pipeline and 385% Branded Generics Growth in Q4

Synopsis: The share jumps 11 percent on strong Q4 performance, driven by robust ANDA (Abbreviated New Drug Application) pipeline and 385 percent growth in branded generics, signall...

Specialty Pharma Hits 5% Following International Distribution Order Worth $1.5 Million

Synopsis:- Speciality Medicines Limited, listed on BSE-SME just 23 days ago, has announced a commercial distribution arrangement with an unnamed international entity for pharmaceut...

This Healthcare Stock Fell 24% After Earnings. One Fund Bought $51 Million Before the Drop

9 Health Care Stocks Moving In Wednesday's Pre-Market Session

Importance Rank:  1 read more